01 March 2017
Continued success and growth has enabled Aptamer Group to restructure its Scientific Operations team. Increasing interest in the development of aptamers against small molecule targets has led to the formation of a dedicated scientific team. This is in addition to the existing team focused on aptamer generation against larger targets (proteins, viruses, cells […]
01 March 2017
AptaBind: Enabling Improved Protein Purification with Aptamer-Mediated Affinity Chromatography (AMAC)
8 February 2017
Aptamer Technology Platform
Aptamers (short, synthetic DNA- or RNA-based molecules) are developed at Aptamer Group under strict laboratory conditions utilising our automated high-throughput selection platform. Aptamers have flexible, sequence specific structures that can form complimentary surfaces to all or part of their target. This structural synergy facilitates strong electrostatic, hydrogen bonding or stacking interactions […]
01 December 2016
World AIDS Day is held on the 1st of December of each year and is an opportunity for people worldwide to unite in the fight against HIV. Around 100,000 are currently living with HIV in the UK and an estimated 35 million people suffer from HIV globally.
Ever since AIDS was first recognized in […]
24 November 2016
Stefan is our Lab Automation Scientist; he has worked in industry for a number of years and has brought his excellent skills and knowledge to Aptamer Group. This week we chat to him as our spotlight…
Hi Stefan, so tell us a little bit about your role here at Aptamer?
My main responsibilities are the […]
10 November 2016
We are thrilled to announce that our CTO Dr David Bunka has been invited to speak at our local Venture Fest here in Yorkshire. The conference will be held on Wednesday 16th November 2016 at York Racecourse.
Organised by Made It York, Venturefest Yorkshire is a one day festival with a clear remit to […]
08 November 2016
Escherichia coli (E. coli) are diverse bacteria, with pathogenic and non-pathogenic strains. The rod-shaped bacterium is a major cause of diarrheal diseases, peritonitis, colitis, urinary tract infections and bacteraemia, costing billions of dollars to treat annually and claiming approximately 2 million lives 1. A BBC News article recently highlighted E. coli as the […]
07 November 2016
This week we caught up with Amy Keelty, our Research Scientist at Aptamer Group! Amy has been working with the company for a number of months now and has become a valuable team member, so it was great to speak to her and learn a little bit more about her role.
Hi Amy, so […]
28 October 2016
Streptococcus pneumoniae (S. pneumoniae) is one of the most common bacterial respiratory pathogens worldwide and responsible for a variety of life threatening infectious diseases including pneumonia, meningitis and septicaemia 1. In the developing world, 25% of all preventable deaths in children under five years old are attributed to pneumococcal septicaemia, with over 1.2 […]
21 October 2016
Staphylococcus aureus (S. aureus) is a gram positive bacterium that can live a double life. Widespread in the environment as a commensal, S. aureus can also be a versatile and dangerous human pathogen. As one of the most commonly isolated pathogens in nosocomial infections S. aureus is adept causing infections in high-risk patients, […]
21 September 2016
It’s been a few weeks since we last did our spotlight feature and this week we are talking to our Business Development Executive Zaid Risheq. Zaid has been part of the team since the beginning of May; let’s hear his thoughts about Aptamer!
Hi Zaid, you are our newest member of staff, what made […]